Abstract
The African trypanosome, Trypanosoma brucei, is a protozoan that causes sleeping sickness in humans and Ngana in livestock. These flagellated parasites are directly exposed to immune defences as they circulate in the mammalian host bloodstream but they maintain persistent infections by undergoing antigenic variation. Central to this process is mono-allelic transcription and switching of the expressed variant-surface glycoprotein (VSG) gene which encodes the vast majority of their dense surface coat. The active telomeric VSG is transcribed by RNA polymerase I in an ‘expression site body’ (ESB) while transcription attenuation occurs at ‘inactive’ telomeres. Here, I review what is known about the molecular mechanisms involved in achieving antigenic variation and outline how we intend to exploit genome sequence and new tools, particularly RNA interference, to identify and characterise factors required for VSG regulation.
Keywords: antigenic variation, genome, rnai, trypanosoma brucei, vsg
Current Molecular Medicine
Title: The Molecular Control of Antigenic Variation in Trypanosoma brucei
Volume: 4 Issue: 6
Author(s): David Horn
Affiliation:
Keywords: antigenic variation, genome, rnai, trypanosoma brucei, vsg
Abstract: The African trypanosome, Trypanosoma brucei, is a protozoan that causes sleeping sickness in humans and Ngana in livestock. These flagellated parasites are directly exposed to immune defences as they circulate in the mammalian host bloodstream but they maintain persistent infections by undergoing antigenic variation. Central to this process is mono-allelic transcription and switching of the expressed variant-surface glycoprotein (VSG) gene which encodes the vast majority of their dense surface coat. The active telomeric VSG is transcribed by RNA polymerase I in an ‘expression site body’ (ESB) while transcription attenuation occurs at ‘inactive’ telomeres. Here, I review what is known about the molecular mechanisms involved in achieving antigenic variation and outline how we intend to exploit genome sequence and new tools, particularly RNA interference, to identify and characterise factors required for VSG regulation.
Export Options
About this article
Cite this article as:
Horn David, The Molecular Control of Antigenic Variation in Trypanosoma brucei, Current Molecular Medicine 2004; 4 (6) . https://dx.doi.org/10.2174/1566524043360078
DOI https://dx.doi.org/10.2174/1566524043360078 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
T Cell-based Therapies for Atherosclerosis
Current Pharmaceutical Design Targeting the Bombesin/Gastrin-Releasing Peptide Receptor to Treat Sepsis
Recent Patents on Anti-Infective Drug Discovery Osmotically Regulated Flow of Flurbiprofen through In Situ Formed Asymmetric Membrane Capsule
Current Drug Delivery The Use of Statins in Hematopoietic Stem Cell Transplantation
Current Stem Cell Research & Therapy A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Current Medicinal Chemistry Therapeutic Targeting of P-Selectin in Atherosclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Transforming Growth Factor-Beta and the Kidney: What We Know and What We Can Do?
Current Enzyme Inhibition Systemic Vasculitis: An Epidemiological Perspective
Current Immunology Reviews (Discontinued) Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms
Current Pharmacogenomics Naturally Occurring NF-κB Inhibitors
Mini-Reviews in Medicinal Chemistry The Two Faces of Interleukin-17A in Atherosclerosis
Current Drug Targets Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
Current Pharmaceutical Design Leptin and Inflammation
Current Immunology Reviews (Discontinued) Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics
Current Pharmaceutical Design Mucosal Vaccination for Prevention of HIV Infection and AIDS
Current HIV Research Homocysteine in Neurology: From Endothelium to Neurodegeneration
Current Nutrition & Food Science Antiplatelet and Antileukocyte Effects of Cardiovascular,Immunomodulatory and Chemotherapeutic Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy
Mini-Reviews in Medicinal Chemistry Editorial [ Bio-Markers as Tools For Discovery of New Psoriasis Therapies ]
Current Drug Discovery Technologies Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases
Current Vascular Pharmacology